Found 0 matching trials
Administration of Two Injections for Multiple Dupuytren's Contractures
PHASE3The objectives of this study are to assess the safety and efficacy of concu...
Location
Tucson Orthopaedic Institute
Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease
PHASE4Our team has previously demonstrated efficacy in performing a novel collage...
Status
Active Not Recruiting
Location
Male Fertility and Peyronie's Clinic
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
PHASE4The purpose of this study is to learn about the safety and side effects of ...
Status
Active Not Recruiting
Location
University of Miami - Desai Sethi Urology Institute
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
PHASE2The study will evaluate the safety, effectiveness, and immunogenicity of EN...
Location
Clinical Testing of Beverly Hills
CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment
N/AThis observational study will prospectively collect data on treatment optio...
Location
Raven Orthopaedics, Inc.
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
NAThe purpose of this research is to determine whether or not low-intensity s...
Location
Mayo Clinic Minnesota
Ultrasound B Mode Imaging and Elastography
N/AA Pilot Study on Ultrasound B mode Imaging and Elastography during administ...
Location
The Center for Rheumatology and Bone Research a division of Arthritis and Rheumatism Associates, P.C.
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
NAA single-center, prospective, randomised controlled clinical trial (1:1 tre...
Location
Peking University Third Hospital
Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders
PHASE4Compare key clinical outcomes between controls and men treated with a novel...
Location
The Male Fertility and Peyronie's Clinic
Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP
PHASE1This study will evaluate the safety and Pharmacokinetics (PK) of a single 3...
Location
Endo Clinical Trial Site #1